CTCF is a master regulator of gene transcription and chromatin organization with occupancy at thousands of DNA target sites. CTCF is essential for embryonic development and somatic cell viability and has been characterized as a haploinsufficient tumor suppressor. Increasing evidence demonstrates CTCF as a key player in several alternative splicing (AS) regulatory mechanisms, including transcription elongation, regulation of splicing factors, and epigenetic regulation.
Introduction
CCCTC-binding factor (CTCF) is a highly conserved, multivalent, 11-zinc finger DNA-and RNA-binding protein, which occupies thousands of conserved target sites distributed across vertebrate genomes and co-ordinates topologically associating domain (TAD) formation [1] [2] [3] [4] [5] . Numerous studies have shown that CTCF regulates diverse biological functions including transcriptional activation and repression, insulation, high-order chromatin organization, X-chromosome inactivation, pre-mRNA splicing, and DNA methylation [6, 7] . CTCF binding occurs in a tissue-specific manner, and the binding sites themselves are highly conserved among different species [2] [3] [4] [5] 8, 9] . Over 30% and 50% of all CTCF binding sites are located in intronic and intergenic regions, respectively [2, 5, 9] .
The ubiquitously expressed transcription factor CTCF exhibits differential expression in mammalian tissues [8, 10, 11] , which require specific CTCF levels for growth, differentiation and development [12] [13] [14] . Homozygous deletion of Ctcf causes early embryonic lethality in mice [15] , while mice harboring a hemizygous deletion of Ctcf (Ctcf +/-) exhibit delayed post-natal growth and development [15, 16] . Sustained Ctcf haploinsufficiency in mice has various pathophysiological implications including spontaneous widespread tumor formation in diverse tissues as well as genome-wide aberrant hypermethylation [17] . Consistent with that, we have shown that CTCF acts as a haploinsufficient tumor suppressor [16, 18, 19] . Nevertheless, the underlying link between Ctcf haploinsufficiency and spontaneous tumor formation remains to be fully elucidated.
Compelling evidence has linked CTCF to alternative splicing (AS) regulation due to its direct or indirect role in modulating splicing decisions via complex mechanisms including RNA Polymerase II (Pol II) elongation, transcriptional regulation of splicing factors, DNA methylation and chromatin organization [20] [21] [22] [23] [24] [25] . Despite its potential importance, the impact of altered CTCF dosage on AS has not been investigated at a global scale. More than 90% of human multi-exonic genes undergo AS in a tissuespecific manner [26, 27] . While normal AS contributes to transcriptome and proteome diversity, aberrant AS can have deleterious effects leading to the development of several pathological complications including cancer [28] [29] [30] . Therefore, identifying potential modulators of AS is critical to fully comprehend the etiology and molecular pathophysiology of cancer.
In this study, we conducted transcriptomic analyses in Ctcf +/mice to explore the impact of Ctcf haploinsufficiency in AS regulation in spleen, brain, kidney, muscle and liver. We found that Ctcf haploinsufficiency induces changes to gene expression and AS that are strikingly tissue-specific. Intron retention (IR), for example, is highly differentially regulated in Ctcf haploinsufficient liver and kidney compared to wildtype (WT) mice. Differential IR could be mediated by Ctcf binding sites located up-and downstream of retained introns.
Results

Ctcf mediates tissue-specific gene expression and alternative splicing
Transcriptomic and proteomic studies have revealed that CTCF is expressed in all mammalian tissues at levels that vary by up to 20-fold [10, 11] . To assess the dosage-dependent impact of CTCF on gene regulation and AS we examined a Ctcf haploinsufficient mouse model harboring a hemizygous deletion of Ctcf. In this model, the entire coding region of one Ctcf allele is replaced with an expression cassette containing the pgk promoter and neomycin gene (Ctcf +/pgkneo , herein referred to as Ctcf +/for simplicity) ( Figure 1A, Supplementary Figure 1 ). We selected five tissues from different body systems for which the relative CTCF expression between tissues is consistent for human and mouse ( Supplementary Figure 2) , including lymphatic (spleen), nervous (brain), urinary (kidney), muscular (quadriceps femoris) and digestive (liver) systems. We isolated all five tissues from 11-week-old female mice comprising Ctcf +/and WT littermates, and validated the reduction of Ctcf mRNA (by 36-41%) and Ctcf protein (the 130 kDa species by 18-59%) expression in Ctcf +/mice by RT-qPCR and Western blotting, respectively (Supplementary Figure 3) . Interestingly, we observed Ctcf expression compensation at the protein level in all tissues except spleen, in which the Ctcf concentration was less than 40% of WT Ctcf protein levels. Apart from the spleen, the increase in Ctcf expression from DNA to RNA and protein suggests that a post-transcriptional dosage compensation of Ctcf may have occurred ( Figure 1B ).
We performed transcriptome analysis in all five tissues to examine differential gene regulation and differential AS between WT and Ctcf +/mice. Ctcf transcript read counts assessed by RNA-seq in Ctcf +/mice were significantly decreased in all tissues (33-39%) compared to WT mice (Figure 2A ). Differential gene expression analysis revealed that Ctcf haploinsufficiency exerts distinct tissue-specific effects.
We detected at least 400 differentially expressed genes (DEGs) per tissue (a total of 3,746 DEGs in all tissues) ( Supplementary Table 1 ). In all tissues other than liver we detected an overall increase in gene expression ( Figure 2B ), supporting Ctcf's role as a transcriptional repressor [6] .
Apart from Ctcf, only six genes (Carmil2, Gm38250, Gsto2, H2-Q7, Thap12 and Zcwpw1) were consistently differentially expressed in all five tissues ( Figure 2C ).
Carmil2, located adjacent to Ctcf at 8qD3, was upregulated in Ctcf +/mice, which was also observed in a similar hemizygous Ctcf +/mouse model [31] . ZCWPW1 in humans is located within a CTCF-mediated TAD and contains a CTCF-bound intronic enhancer. A polymorphism (rs1476679) in this enhancer has been associated with increased disease risk in late onset-Alzheimer's disease by affecting CTCF binding and chromatin topology [32, 33] . A relationship between CTCF and the other four genes has not been established yet.
Gene Ontology (GO)-based annotation enrichment analysis of all the significant DEGs revealed a strong enrichment of tissue-specific biological processes (Supplementary Figure 4 ). GO terms related to metabolism, immune response, and cellular component organization were commonly affected by Ctcf haploinsufficiency ( Figure 2D ). These data confirm that a decrease in Ctcf dosage through haploinsufficiency can impact gene-expression in a tissue-specific manner.
To examine the effect of Ctcf haploinsufficiency on the AS landscape, we analyzed differential AS events in Ctcf +/using rMATS [34] . We found that exon skipping (ES)
is the most abundant form of differential AS detected in all tissues (Supplementary   Table 2 ). Notably, we observed a significant increase in IR events in the liver and kidney of Ctcf +/mice ( Figure 2E ), which is in contrast to all other forms of AS.
However, a decrease in Ctcf-mediated IR events was only detected in Ctcf +/muscle.
Overall, our analysis shows that Ctcf haploinsufficiency not only affects gene expression but also perturbs the AS landscape in a tissue-specific manner.
Characterization of intron retention in Ctcf +/liver
To confirm that Ctcf haploinsufficiency modulates IR in a tissue-specific manner, we used IRFinder, a software package specifically developed for the detection and quantification of IR [35] [36] [37] . We confirmed that IR is increased in Ctcf +/liver and kidney with a total of 60 and 43 upregulated IR events, respectively. Only 1 and 5 IR events were downregulated in Ctcf +/liver and kidney, respectively ( Figure 3A , Supplementary Table 3 ). Moreover, we detected that in some mRNA transcripts (5 in liver and 1 in kidney) multiple introns are retained in the same transcript. There were no IR events common to all tissues. Interestingly, we found that a larger number of splicing factors, including Srsf1, Prpf40b, Thoc1, Khsrp and Zpr1, exhibited retained introns in Ctcf +/liver than other tissues (Supplementary Figure 5 ).
As Ctcf haploinsufficient liver exhibited the most dramatic upregulation of IR, we explored these IR events for further validation and characterization. First, we calculated the IR-ratio for all IR events (Supplementary Figure 6A ). The IR-ratio is the proportion of intron-retaining mRNA transcripts compared to all mRNA transcripts from the same gene. Consistent with previous studies, we considered IR events with an IR-ratio ≥ 0.1 as biologically significant [35, 38] . Since we previously showed that IR can reduce the expression of the host gene via nonsense-mediated decay [36], we examined the intronic expression as well as expression of host mRNA. We observed that 65% of differential intron-retaining genes, whether up-or downregulated, exhibited increased gene expression (Supplementary Figure 6B ). This suggests that Ctcf haploinsufficiency triggers both the upregulation of expression and IR-ratios of intron-retaining genes in liver. We selected five candidates exhibiting increased IR, including Gadd45g, Plk3, Rfx5, Ppox and Setd4 ( Figure 3B ), for validation by RT-qPCR. We confirmed a significant increase in retained introns in all five genes ( Figure 3C ), however the impact on host mRNA expression varied ( Figure 3D ). We have recently summarized all possible fates of intron-retaining transcripts [39, 40] . Apart from their degradation via nonsensemediated decay, fates include the nuclear detention of intron-retaining transcripts, the synthesis of novel protein isoforms, or their cellular translocation.
We next examined the molecular features of differential IR events identified in Ctcf +/liver and found that retained introns are shorter ( Figure 3E ) and have a higher GC content than non-retained introns (p < 0.0001, Figure 3F ), consistent with our previous reports [36, 38, 41] . To further characterize the liver-specific intron-retaining genes, we performed annotation enrichment analysis and found that the affected genes are associated with biological processes and pathways related to metabolism, cytoskeletal organization, RNA splicing and mRNA processing ( Figure 3G ). These findings show that Ctcf haploinsufficiency induces IR of specific introns in liver genes involved in splicing-and metabolism-related processes.
Enrichment of Ctcf binding sites proximal to differentially retained introns
CTCF ChIP-seq studies have found that approximately 30% and 50% of CTCF binding sites are located in intronic and intergenic regions, respectively [2, 5, 9] . It has been shown that the intragenic localization of CTCF binding sites influences pre-mRNA splicing decisions leading to alternative exon splicing [20, 21, 25] . To determine whether Ctcf binding sites are enriched in the proximity of retained introns in liver, we analyzed a publicly available ChIP-seq data set from C57BL/6 normal mouse liver (E-MTAB-5769) [42] .
We examined Ctcf binding sites 200-50,000 nt upstream and downstream of differentially retained introns as well as within each intron. We found that there were more Ctcf binding sites up-and downstream of retained introns compared to expressed non-retained introns ( Figure 4A ). The fold difference in Ctcf ChIP-seq peaks was higher, both up-and downstream, in regions close to the splice sites (< 2000 nt). In the intron bodies, we observed a non-significant difference in the mean number of Ctcf peaks. The slightly higher mean number of ChIP-seq peaks observed in non-retained introns, could be explained by the fact that retained introns are shorter. These findings suggest that the Ctcf haploinsufficiency-induced IR we observed in liver mostly affects short and GC-rich introns which are proximal to Ctcf binding sites.
Discussion
IR is a widespread and conserved mechanism of post-transcriptional gene expression regulation affecting over 80% of all protein coding genes [35] . For instance, we have previously shown that IR regulates differentiation across diverse hematopoietic lineages [36, 38, 41] . Moreover, the majority of cancer types have abundant IR events that affect their transcriptomes, including genes involved in RNA splicing [43, 44] . Therefore, identifying the potential modulators of AS, particularly IR, is essential to fully comprehend the etiology and molecular pathophysiology of cancer.
Here, we demonstrate that Ctcf haploinsufficiency, which has previously been shown to induce spontaneous tumor formation in mice and genome-wide hypermethylation [17] , also perturbs the AS landscape. Upon examining a number of tissues, we observed a specific increase of IR in Ctcf +/liver and kidney. Moreover, we observed a similar tissue-specific effect of Ctcf haploinsufficiency on gene expression. Given that CTCF expression and DNA occupancy are variable between tissues [2] [3] [4] [5] 8, 9] , these differences may govern how CTCF specifically regulates the transcriptome and AS in tissues.
While the impact of CTCF haploinsufficiency on the global AS landscape has not been previously investigated, we utilized this model to examine in vivo the global effect of Ctcf dose-dependent regulation on AS in specific tissues. Although we used
Ctcf hemizygous mice, we and others have shown that any sustained decrease in CTCF expression is partially compensated at the protein levels [17, 31] . However, with a less than 50% reduction (except spleen) of Ctcf mRNA and protein expression, we observed tissue-specific differences in gene expression and AS.
These data suggest that more prominent effects might be observed with loss-offunction mutations or the inactivation of CTCF, which are commonly observed in cancer [7, 45] , or at an even lower CTCF dosage. However, we have previously shown that the enforced genetic ablation of CTCF has a negative impact on somatic cell viability [16] .
Although the exact mechanism underlying Ctcf haploinsufficiency-mediated IR regulation remains to be characterized, several possibilities can be proposed based on our data and previous studies. An optimal RNA Pol II elongation rate is essential for constitutive splicing [46]; therefore, both slow and fast RNA Pol II elongation rates were observed to promote IR [47] . Slowing RNA Pol II elongation mediated by CTCF promoted exon inclusion in B-lymphoma cell lines, providing the first evidence for a role of CTCF in AS. Binding of CTCF downstream of CD45 exon 5 leads to decelerating RNA Pol II elongation, thus permitting exon 5 inclusion [20] . This mechanism is tightly regulated by cytosine methylation at CTCF binding sites in the DNA by the methylcytosine dioxygenases TET1 and TET2 [21] . In another example, CTCF binding to the BDNF2a locus was shown to be essential for its splicing by inhibiting TET1-induced DNA methylation and the subsequent interaction between TET1, MeCP2 and the splicing factor YB1 [22] . In contrast, DNA methylation at CTCF binding sites located upstream or downstream of alternatively spliced exons was associated with inclusion of exons [24] . Knowing that CTCF regulates DNA methylation and preserves methylation-free regions throughout the genome [48-50], we propose that CTCF regulates AS in a locus-dependent and tissue-specific manner.
CTCF has been recognized as a coordinator of chromatin looping and architecture [51] [52] [53] . Of immediate relevance is the observation that the RNA Pol II elongation rate can be controlled by chromatin organization and influence AS decisions [54, 55] .
A recent study showed that CTCF-mediated chromatin loops formed between promoters and intragenic regions, particularly at upstream sites of alternatively spliced exons, lead to exon inclusion [25] . However, this mechanism still requires further validation. Overall, these studies suggest a role for CTCF as a key modulator of splicing decisions at individual loci via different molecular and epigenetic mechanisms.
Given its global transcriptional regulation and insulation functions [6] , altering CTCF expression could perturb various transcriptional signaling pathways and subsequently AS. In this context, reduced CTCF expression was found to be associated with increased exon exclusion, particularly in those exons located 1 kb upstream of CTCF binding sites in BL41 and BJAB B-lymphoma cells [20] . This suggests that reduction of CTCF expression and the distribution of CTCF binding sites can influence pre-mRNA processing decisions. Consistent with that, we showed that enrichment of Ctcf binding sites upstream and downstream of retained introns in liver is associated with increased IR. From these results we speculate that CTCF may regulate IR through modulating the RNA Pol II elongation rate and methylation status at CTCF target binding sites located proximal to retained introns ( Figure 4B ).
Our data supports previous observations from our group and others that IR mostly affects introns which are short and GC-rich [36, 38, 56] . During granulocytic differentiation, some intron-retaining transcripts undergo nonsense-mediated decay, triggered by premature termination codons located within the retained introns [36].
This process can lead to an overall reduction of gene expression consequent to IR.
Here, we observed a net increase in gene expression in the liver of Ctcf +/mice, suggesting an alternative predominant fate of intron-retaining transcripts.
We observed that there was an enrichment of genes related to RNA splicing and metabolism among the intron-retaining genes. Splicing factors affected by IR particularly in Ctcf +/liver and kidney such as Srsf1, Esrp2 and Prpf40b have been previously reported to be associated with the regulation of AS including IR [35, 57, 58] . In addition to splicing, genes involved in metabolic processes were affected by IR in Ctcf haploinsufficient liver. We previously reported that Ctcf haploinsufficient mice exhibit ~14% reduction in body weight during post-natal development [16] . Given that the liver plays an essential role in organismal metabolism, we propose that Ctcf-regulated IR in liver may affect metabolic genes and pathways that contribute to this body weight phenotype. Ctcf is a haploinsufficient tumor suppressor that induces spontaneous tumor formation in various mouse tissues including liver [17] . The liver exhibited the most abundant IR events observed in our study. Given the fact that IR is upregulated in most human cancers including liver cancer [43], a new link between CTCF haploinsufficiency and hepatocellular carcinoma causation via IR may be possible.
In this study, we have further defined the role of Ctcf in AS regulation and found Ctcf dosage-dependent effects on tissue-specific gene expression. Our analysis of Ctcf binding sites around retained introns in normal liver confirmed their relevance especially in concurrent with short and GC-rich introns. To gain a mechanistic understanding of tissue-specific IR in Ctcf haploinsufficiency, additional studies are required that focus on Ctcf DNA occupancy and the interplay with the epigenetic regulation of AS. Moreover, causal links between Ctcf haploinsufficiency, IR, and increased tumor formation should be further investigated.
Materials and methods
Mouse model, genotyping and organ collection
All mouse experiments were conducted in accordance with the New South Wales Organs of interest (brain, kidney, liver, muscle and spleen) were collected and snapfrozen in liquid nitrogen, and stored at -80˚C.
Protein extraction and quantitation
To extract protein from mouse organs, a small piece of the organ was minced in ice- 
Western blot, antibodies and densitometry
For Western blot analysis, protein extracts were prepared as equal aliquots (10 μg) and boiled in 2X protein loading buffer containing NuPAGE LDS Sample Buffer and 100 mM Dithiothreitol (DTT) for 5 minutes. The samples were then resolved by 4-12% SDS-PAGE using NuPAGE Bis-Tris Protein Gel system (Thermo Fisher Scientific), and transferred onto a PVDF membrane (Merck Millipore) in a semi-dry transfer apparatus. Rabbit polyclonal anti-CTCF (1:2,000; #3418, Cell Signaling) or mouse monoclonal anti-GAPDH (1:5,000 dilution; ab8245; Abcam) was used as a primary antibody, followed by washing and staining with horseradish peroxidaseconjugated donkey anti-rabbit or anti-mouse IgG secondary antibodies (1:5,000 dilution; Merck Millipore), respectively. A Chemidoc Touch (BioRad) was used to visualize the protein bands on these replicate blots, which were subjected to densitometric analysis using ImageJ software.
RNA isolation, purification and quantitation
To isolate RNA from WT and Ctcf +/tissues of interest, a small piece of tissue (<30 mg weight) was homogenized with TRIzol reagent (Invitrogen) followed by isopropanol precipitation at -80˚C. Next, contaminating DNA was eliminated by using the TURBO DNA-free kit (Invitrogen). The RNA quantitation and quality were assessed by NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific). Only samples with a 260/280 nm absorbance ratio of 1.9 or above were used. The RNA integrity was evaluated using a 2100 Bioanalyzer with the RNA 6000 Nano kit (Agilent) where samples with an RNA integrity number (RIN) below 7 were excluded.
RT-qPCR
To determine the relative expression level of Ctcf mRNA, cDNA was synthesized using SuperScript III Reverse Transcriptase (Invitrogen) followed by RNaseOUT treatment (Invitrogen). Next, qPCR was performed on the cDNA with SYBR Green 
RNA sequencing
A total of thirty RNA samples (five tissues collected from three biological replicates of WT and Ctcf +/mice), which met the quality control parameters described above, were sent to Novogene (Beijing, China) for library preparation (strand-specific, poly-A enriched) and RNA-seq (150 bp paired-end reads, over 100 million reads) using the Illumina HiSeq-PE150 platform.
Bioinformatic analysis
Initial quality control of the RNA-seq raw data was conducted using FastQC (bioinformatics.babraham.ac.uk/projects/fastqc) and MultiQC (multiqc.info) to check for sequencing quality prior to analysis [59] . After passing the quality control check, reads were mapped to the mouse reference genome GRCm38/mm10 using STAR software [60] . To examine differential gene expression in WT and Ctcf +/tissue samples, read counts were determined using featureCounts 1.5.0-p3 [61] and then subjected to differential gene expression analysis using the R Bioconductor package DESeq2 1.25.15 [62] . Genes with low read counts (<5) across all samples were removed. Differential AS was analyzed using rMATS 4.0.1 [34] , while further analysis of differential IR was performed using IRFinder 1.2.5 [35] . Specific IR features such as intron length and GC content were calculated using BEDTools v2.26.0 [63] . GO analysis of differentially expressed genes and intron-retaining genes were performed using the DAVID 6.8 online tool [64] .
Validation of retained-intron candidates
Several candidates from the subset of intron-retaining transcripts in Ctcf +/liver, were selected for validation by RT-qPCR according to stringent filtering parameters from the main IRFinder output file. These filtering parameters included mean IR-ratio ≥0.1, mean intron coverage >75%, mean intron depth ≥5 reads, mean splice junction depth ≥20 reads, and p-value of IR-ratio fold-change between WT and Ctcf +/samples <0.05. Further details of these parameters are provided in the IRFinder manual (github.com/williamritchie/IRFinder/wiki). Selected differentially retained introns were also visually inspected using the Integrative Genomics Viewer software (software.broadinstitute.org/software/igv/).
Next, the selected candidates were validated by RT-qPCR using a set of three specific primers ( Supplementary Table 4 ). To measure the relative mRNA expression, two primers were used to amplify sequence spanning the exonic region adjacent to the retained intron (Forward) to cross the exon-exon junction flanking the retained intron (Reverse 1). To measure the retained intron in the target spliced isoform, a third primer was designed to anneal within the intronic region of the retained intron (Reverse 2). Finally, the relative mRNA expression was calculated as described above while intron-retaining transcript expression was calculated after normalizing its expression to the expression of the intron's flanking exons.
Statistical analysis
The data from this study was analyzed using different statistical tests relevant to the type of experiment or analysis. Wald test and unpaired two-tailed Student's t-test (as 
Data availability
Data have been submitted to GEO under accession number (GSE140532). 
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